The t(9;22) in chronic myelogenous leukemia (CML) may be reciprocal or, in a minority of cases, may result in an extensive deletion of a portion of the major breakpoint cluster region (M-bcr) of the BCR. This report provides evidence of the duplication of small segments within the M-bcr in a small group of patients with CML. Southern blots of Bgl II and Bgl II/BamHI double-digested DNA from the blood or bone marrow of 46 patients with CML were probed with a 5 1.4-kb Taq I/Hindlll M-bcr probe and a 3 2-kb Hindllll BamHl M-bcr probe. In three patients, rearrangements were noted with both probes in Bgl Il-digested DNA, but were not present in Bgl II/BamHI-digested DNA with either probe. Southern analysis of DNA samples double-digested with Bgl II and BspHl from two of these three cases showed no rearrangements with either probe; the M-bcr BspHl site is located 26 bp 3 of the BamHl site in the second intron of the M-bcr. The presence of a rearranged M-bcr with both HRONIC myelogenous leukemia (CML) is a clinically C and morphologically distinct hematopoietic stem cell neoplasm. Patients generally present in the chronic phase with splenomegaly, a marked neutrophilia with a left shift, basophilia, and thrombocytosis. Most patients progress to a terminal, therapy-resistant acute leukemia within 5 years of diagnosis. ' Cytogenetically, the Philadelphia chromosome (Ph) is found in 90% to 95% of CML patients. At the molecular level, this translocation represents the aberrant conjoining of the c-ab1 proto-oncogene from chromosome 9, with the breakpoint cluster region gene (BCR) on chromosome 22. This hybrid gene is transcribed and translated into a chimeric protein product that is considered essential in the pathogenesis of Ph-positive malignancies. Although the breakpoints on chromosome 9 are widely scattered, the translocation breakpoints on chromosome 22 are relatively tightly clustered within a 5.8-kb region referred to as the major breakpoint cluster region (M-bcr). This tight clustering of breakpoints on chromosome 22 has rendered this region amenable to extensive study by conventional Southern blot analysis. '-3 Although the majority of cases of CML shows the predicted rearranged bands within the M-bcr by Southern blot analysis, rearrangements with atypical molecular findings may occur. These include extensive deletions of the 3' portion of the Mbcr and breakpoints located outside the M -b~r .~,~ Additional aberrancies have also been described in which cleavage by enzymes predicted to flank the translocation breakpoint produces "pseudogermline" or apparently unrearranged bands6 We report a small group of such cases showing a pseudogermline configuration of the M-bcr on Southern analysis and propose that this phenomenon is due to a duplication of small segments within M-bcr sequences in some cases.
The t(9;22) in chronic myelogenous leukemia (CML) may be reciprocal or, in a minority of cases, may result in an extensive deletion of a portion of the major breakpoint cluster region (M-bcr) of the BCR. This report provides evidence of the duplication of small segments within the M-bcr in a small group of patients with CML. Southern blots of Bgl II and Bgl II/BamHI double-digested DNA from the blood or bone marrow of 46 patients with CML were probed with a 5 1.4-kb Taq I/Hindlll M-bcr probe and a 3 2-kb Hindllll BamHl M-bcr probe. In three patients, rearrangements were noted with both probes in Bgl Il-digested DNA, but were not present in Bgl II/BamHI-digested DNA with either probe. Southern analysis of DNA samples double-digested with Bgl II and BspHl from two of these three cases showed no rearrangements with either probe; the M-bcr BspHl site is located 26 bp 3 of the BamHl site in the second intron of the M-bcr. The presence of a rearranged M-bcr with both HRONIC myelogenous leukemia (CML) is a clinically C and morphologically distinct hematopoietic stem cell neoplasm. Patients generally present in the chronic phase with splenomegaly, a marked neutrophilia with a left shift, basophilia, and thrombocytosis. Most patients progress to a terminal, therapy-resistant acute leukemia within 5 years of diagnosis. ' Cytogenetically, the Philadelphia chromosome (Ph) is found in 90% to 95% of CML patients. At the molecular level, this translocation represents the aberrant conjoining of the c-ab1 proto-oncogene from chromosome 9, with the breakpoint cluster region gene (BCR) on chromosome 22. This hybrid gene is transcribed and translated into a chimeric protein product that is considered essential in the pathogenesis of Ph-positive malignancies. Although the breakpoints on chromosome 9 are widely scattered, the translocation breakpoints on chromosome 22 are relatively tightly clustered within a 5.8-kb region referred to as the major breakpoint cluster region (M-bcr). This tight clustering of breakpoints on chromosome 22 has rendered this region amenable to extensive study by conventional Southern blot analysis. '-3 Although the majority of cases of CML shows the predicted rearranged bands within the M-bcr by Southern blot analysis, rearrangements with atypical molecular findings may occur. These include extensive deletions of the 3' portion of the Mbcr and breakpoints located outside the M -b~r .~,~ Additional aberrancies have also been described in which cleavage by enzymes predicted to flank the translocation breakpoint produces "pseudogermline" or apparently unrearranged bands6 We report a small group of such cases showing a pseudogermline configuration of the M-bcr on Southern analysis and propose that this phenomenon is due to a duplication of small segments within M-bcr sequences in some cases.
MATERIALS AND METHODS
The study material consisted of bone marrow or blood samples from 46 patients with CML collected at the University of Minnesota. Approval for examination of this tissue was obtained by the Committee on the Use of Human Subjects in Research at the University of Minnesota. Genomic template DNA used in the PCR
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probes in Bgl Il-digested DNA and the lack of rearrangement in Bgl II/BamHI and Bglll/BspHI double-digested DNA suggest the presence of M-bcr BamHl and BspHl sites on both 9q -I-chromosome (9q + ) and the Philadelphia chromosome (Ph). This implies a duplication of at least the 26-bp M-bcr BamHIIBspHI fragment in these two samples. Sequence data from one of these t w o cases confirmed the Mbcr breakpoints to be staggered; the Ph M-bcr breakpoint occurred 258 bp downstream from the 9q + M-bcr breakpoint. It is concluded that a duplication of small segments within the M-bcr occurs in a small group of patients with CML, which may lead to pseudogermline patterns on Southern blot. Such a duplication may provide insight into the mechanism of some chromosomal translocations in neoplasia. 0 1993 by The American Society of Hematology.
production of some of the probes used in this study was derived from blood leukocytes from healthy volunteers.
DNA extraction, restriction enzyme digestion, Southern transfirs, and hybridization. Peripheral blood and bone marrow cells were lysed in TNE (10 mmol/L Tris-CI, pH 8.0, 100 mmol/L NaCI, 1 mmol/L EDTA) buffer in the presence of 1% sodium dodecyl sulfate (SDS). High molecular weight DNA from the cells was fiuther purified by standard proteinase K treatment (Boehringer-Mannheim Biochemicals, Indianapolis, IN) at a final concentration of 0.1 mg/mL. The specimens were ethanol precipitated after several phenol-chloroform extractions. RNase treatment was followed by several more phenol-chloroform extractions and a final ethanol precipitation. ufacturer's methods were used for transferring the electrophoretically separated restriction fragments to Genescreen Plus nylon membranes (Dupont, Inc. Boston. MA).
The probes and Bs/EII-digested X DNA were radiolabeled with '*P using the random primer reaction.' The filters were prehybridized. hybridized, stripped, and rehybridized all according to manufacturer's recommendations (Genescreen Plus: Dupont. Inc). Washes were adjusted to the background radioactivity with a final wash in 1 .OX to 0.2X standard saline citrate (SSC) solution (0.01 5 mol/L NaCI. 0.0075 mol/L sodium citrate) and 0.1% SDS at 60°C to 65°C. The filters were exposed to Kodak XAR-5 films (Eastman Kodak Co, Rochester, NY) at -85°C for 24 hours to several days.
The probes used in this study were either the 5' most Tu9 I/llindIlI 1.4-kb fragment of the M-hcr (probe I , Fig I) , the 3' most 2-kb //indlIl/Buf?~Hl fragment of the M-bcr (probe 2. Fig I) , the 370-bp Hi~1dIIl/A4.~p I fragment from the second exon and intron of the M-bcr (probe 3. Fig 3) . the 260-bp Scu IITu9 I fragment from the third intron ofthe M-bcr (probe 4. Fig 3) . and the 250-bp BumHI/ exon 3 M-bcr fragment ("Dup" probe, Fig 4) . The plasmid containing probe 1 was provided by the American Type Culture Collection (Rockville. MD). The plasmid containing probe 2 was kindly provided by Dr David Leibowitz (Department of Medicine. Indiana University. Indianapolis, IN). Probes 3,4. and "Dup" were derived by polymerase chain reaction (PCR) methodology. Briefly. for probe 3, a primer pair to the second and third M-bcr exons was synthesized from previously published sequence data (Table I . primers PI and P2'). Five hundred nanograms ofgenomic DNA was added to 100 pL of a PCR mixture containing 1.5 mmol/L MgCI2. 50 mmol/L KCI, IO mmol/ L Tris-HCI. pH 8.3, 200 pmol/L dNTP, 20 pmol of each primer. and 2.5 U of Tu9 I DNA polymerase. After initial denaturation at 95°C for 3 minutes. denaturation. annealing. and extension were performed on a DNA Thermal Cycler (Perkin Elmer-Cetus, Norwalk, CT) at 95°C for I minute, 60°C for I minute. and 72°C for I minute and 30 seconds. respectively, for 35 cycles. The 800-bp amplified product was then purified using a PCR Magic Preps (Promega Corp. Madison. WI) column and subsequently doubledigested with Hind111 and .Msp 1. The 370-bp I/indlll/A4.sp I M-bcr fragment was then isolated in and excised from a 2% NuSieve agarose (FMC Corp. Rockland. ME) gel. The fragment was then purified over a PCR Magic Preps column. The 250-bp "Dup" probe (BumHl/exon 3 Mbcr fragment) was isolated in the same fashion from the same 800-bp amplification product digested with BumHl only. The 260-bp Scu I/Tuq I M-bcr fragment (probe 4) was isolated in a similar manner, frohcx fragment was produced that yielded the 200-bp probe 4 after Tu9 I/ Scu I double-digestion.
The M-bcr consensus sequence in Fig 5 is derived from previous data and methodology" (personal communication to Genome Data Base, Baltimore, MD. March, 1992). The Ph and 9q+ sequences were derived from one of the cases using the inverse PCR method." Briefly. for the Phderived sequence, 100 ng of Tu9 Idigested patient DNA was ligated overnight at 16°C in 90 pL PCR buffer (1.5 mmol/L MgCI2. 50 mmol/L KCI, IO mmol/L Tris-HCI. pH 8.3) with 3 Weiss units ofT4 DNA ligase and 0.8 mmol/L dATP. The mixture was then incubated at 65°C for IO minutes to inactivate the ligase and the circularized M-bcr region was linearized by restricting with 30 U BufnHI for 20 minutes at 37°C in the same reaction vessel. After incubation at 95°C for IO minutes, the remaining dNTPs (dGTP. dTTP. and dCTP), two primers (Table I. S7 and S8 for the 9q+ breakpoint). and 2.5 U of Tuq I DNA polymerase. Amplification was performed using the same cycle parameters as for probe production above. The amplified products were then inserted into PUC 19. cloned. and sequenced as described above. (Fig I , probe 1 and probe  2, respectively) . Specimens from 6 patients showed rearrangement with only the 5' probe and I showed rearrangement with only the 3' probe. These 7 samples were considered to have a M-bcr deletion involving the probed sequence and were not further studied. The remaining 39 specimens showed rearrangement by Southern blot with both 5' and 3' M-bcr the Same cycle parameters as described above. Two amplification products were identified on a 5% polyacrylamide gel, a germline band at 556 bp and a rearranged band at 700 bp. The 700-bp band was excised from a low melting point agarose gel. restricted with Tu9 I, and inserted into a PUC19 vector. The resulting double-stranded plasmid was subsequently cloned and directly sequenced using a Sequenase version 2.0 kit (US Biochemicals, Inc, Cleveland, OH). The 9q+ derivative chromosome sequence was derived in a similar fashion except that ( I ) 100 ng of Piw II/Scu I-digested patient DNA was the starting material. (2) no BurnHI linearization was performed, and (3) the primers used i n the amplification were further 3' in location (Table I . S3 and s4: Fig 5) . Amplification yielded four DNA fragments of 125. 150. 500. and 700 bp in length. The Msp ldigested 500-bp fragment was ligated into PUC19. which was subsequently cloned and sequenced: this fragment yielded the 9q+ M-bcr breakpoint of this case. The sequence data in this case were confirmed by direct genomic amplification and sequencing using primers complementary to M-bcr exons and to the c-ah/ oncogene sequence derived from the above inverse PCR method ( Fig  I) . The finding of a germline restriction digest pattern was problematic as digestion with a flanking restriction enzyme (Bg/ 11) demonstrated rearrangement within this region. In this latter group of 3 patients, Bg/ II/BspHI doubledigested DNA was screened by Southern blot analysis with the 5' and 3' probes to exclude the serendipitous alignment of BumHl sites on the Ph and 9q+ derivative chromosomes (Fig 2) . As with the Bg/ II/BamHI digests, no rearrangements with either probe were found in two of the three cases. The presence of a rearranged M-bcr with both probes in Bg/ Ildigested DNA and the lack of rearrangement in Bg/ II/BumHI and Bg/ II/BspHI doubledigested DNA suggest the presence of chromosome 22derived BumHl and BspHI sites on both chromosome 9q+ and the Ph chromosome. This implies that the M-bcr BamHI/BspHl fragment is duplicated in these cases of CML.
RESULTS

DNA digested with
The breakpoints from one case in this third group was extensively restriction mapped without assuming reciprocity in the translocation event (Fig 3) . Using the 5' HindIII/Msp I fragment of the M-bcr as a probe in Southern blot assays (Fig 3, probe 3 ), rearrangements were noted in the Bg/ II and Bg/ II/Sca I digests; no rearrangements were noted in the Tu9 I, Bg/ II/BumHI, or Bg/ II/BspHI digests. This indicates that the breakpoint on the Ph occurred in the 263-bp BspHI/Scu I fragment of the M-bcr. Using the Scu I/Tu9 I fragment of the M-bcr as a probe in Southern blot assays (Fig 3, probe  4) , rearrangements were noted in the Bg/ II and Tu9 I digests only; no rearrangements were found in the Bg/ II/Sca I, Bg/ II/BspHI, or Bg/ II/BumHI digests. This indicates that the breakpoint on 9q+ occurred in the 20-bp To9 I/BarnHI fragment of the M-bcr.
The BumHIIScu I fragment of the M-bcr was used as a probe in Bgl 11-digested DNA in a Southern blot assay from this one case (Fig 4, "Dup" probe) . This yielded two rearranged fragments and one germline fragment. Because the BarnHI/Sca I M-bcr fragment is intact on chromosome 9q+, the presence of two rearranged fragments indicates that the probed sequence is present elsewhere in the genome of this case and is, therefore, at least partially duplicated. Reprobing of the blot with the 5' M-bcr probe (Fig 4, probe 1) identified one of the rearranged fragments (Ph chromosome) while reprobing with the 3' probe (Fig 4, probe 2) identified the other rearranged fragment (9q+ chromosome). This indicated that the partially duplicated BamHI/Sca I sequence was located on both the Ph and 9q+ chromosomes.
Sequence confirmation of the duplication was obtained through inverse PCR techniques (Fig 5) . Briefly, this case was screened with various restriction enzyme/primer pair combinations. A combination of Tu9 I digestion ofgenomic DNA followed by ligation and amplification with primers to intervening sequence II (IVS 11) of the M-bcr yielded a germline 556-bp fragment and a 700-bp rearranged fragment. Cloning and subsequent sequencing of the 700-bp fragment showed it to be derived from the Ph chromosome with a breakpoint occurring at base 55 of M-bcr exon 111. Double-digestion of genomic DNA with Pvu II/Sca I, followed by ligation and amplification with M-bcr exon Ill primers, yielded 4 fragments between 125 bp and 700 bp in length. Cloning and sequencing of the 500-bp DNA fragment showed this fragment to be derived from the 9q+ M-bcr sequence, with a breakpoint located 12 bp 5' of the IVS I1 BamHl site of the M-bcr. With the sequence data generated above, primers to the c-ab1 portion of both the 9q+ and Ph chromosome were generated and used to amplify, sequence, and verify the respective breakpoints directly from genomic DNA from this case. The sequence-derived breakpoints corroborated Southern blot-derived breakpoints. This indicates that a 258-bp region of the M-bcr is duplicated in this case and is present on both the Ph chromosome and 9q+ chromosome.
DISCUSSION
The Ph has generally been regarded as a reciprocal translocation between chromosomes 9 and 22, although cases with extensive deletions have been described." This study provides evidence that duplications of the M-bcr may occur. The Southern blot data indicate that Bgl 11-digested DNA from 3 of 46 patients with CML demonstrate a M-bcr rearrangement with both 5' and 3' M-bcr probes, yet, when doubledigested with Bgl I1 and BamHI, show no M-bcr rearrangement with either probe. Furthermore, DNA from two of these three cases double-digested with Bgl I1 and BspHI, a unique M-bcr enzyme site located within 30 bp ofthe M-bcr BamHI site, also show no rearrangement with either probe. Serendipitous alignment of two separate restriction enzyme sites is unlikely. In addition, sequence data indicate that a 258-bp M-bcr fragment in one of these cases is duplicated: the breakpoint locations are verified in this case by fine restriction mapping using probes flanking the duplicated area. Southern blot analysis using a probe sequence contained within this duplicated region demonstrates hybridization with both the Ph and 9q+ chromosomes. 
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The presence of a duplicated segment within the M-bcr involved in the Ph raises several significant issues. First, molecular identification of this translocation by Southern blot analysis is commonly used as a diagnostic procedure. The presence of duplicated sequences may create false germline patterns with some restriction enzyme digests, further emphasizing the need to use several restriction enzymes. An M-bcr duplication can confound breakpoint mapping by Southern blot; this may, in part, explain why some studies have suggested that M-bcr breakpoint location is important in the prognosis of CML, whereas other studies could not substantiate this.12 The interpretation of Southern blots in these cases has been made under the assumption of complete reciprocity in the translocation event. Duplicated regions of the M-bcr involving restriction sites invalidate this assumption and data from mapping studies should be reinterpreted in this light.
Finally, the presence of a duplication of greater than 200 bp within the M-bcr raises questions as to the mechanism of the translocation event. The presence of a relatively large duplicated sequence militates against simple double-stranded breaks on each chromosome with religation. Short duplicated segments have been described both in cases of Ph-positive acute lymphoblastic leukemia and in cases of follicular lymphoma carrying the t ( 14; 1 8) . 13314 The investigators in these cases postulated a staggered break on one chromosome of the translocated pair, with subsequent single-stranded ligation and filling of the singlestranded defect. However, both of these cases represented short duplicated sequences of 4 bp or less; it is unclear if the staggered-break hypothesis is tenable in a duplication of the size reported here.
A number of additional hypotheses may also be considered. The relevant segment of DNA may be duplicated within the M-bcr before the translocation event and the breakpoint may occur between the duplicated sequences. Conversely, the duplicated sequence may exist on chromosome 9 before the translocation event, creating a potential site for homologous recombination. Neither of these scenarios has been previously identified. The possibility of a rare polymorphism in the patient studied in detail cannot be excluded as neither parental nor cellular DNA lacking the Ph was available in this case. Alternatively, the duplication could arise as a consequence of the translocation event itself. Aberrant DNA replication with asymmetric strand switching between the BCR gene and c-ab1 oncogene could explain such an observation.
